{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:30:51Z","timestamp":1793619051892,"version":"4.5.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["22367007, 22567014"],"award-info":[{"award-number":["22367007, 22567014"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science Foundation of Hainan Province","award":["824RC500"],"award-info":[{"award-number":["824RC500"]}]},{"name":"Fundamental Research Funds for Hainan University","award":["KYQD(ZR)23002"],"award-info":[{"award-number":["KYQD(ZR)23002"]}],"id":[{"id":"https:\/\/ror.org\/03q648j11","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/13543776.2026.2725660","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:02:16Z","timestamp":1787803336000},"page":"993-1010","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming the blood\u2013brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020\u2013present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Daowei","family":"Huang","sequence":"first","affiliation":[{"name":"Hebei University of Science and Technology","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roujun","family":"Lu","sequence":"additional","affiliation":[{"name":"Hainan University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijing","family":"Tang","sequence":"additional","affiliation":[{"name":"Hebei University of Science and Technology","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Sun","sequence":"additional","affiliation":[{"name":"Hebei University of Science and Technology","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipei","family":"Sang","sequence":"additional","affiliation":[{"name":"Hainan University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872211311666171010123958"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081041"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01717-z"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869269"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00745-5"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176724"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117123"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.02.030"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108245"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115253"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2169682"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106007"},{"key":"e_1_3_4_15_1","unstructured":"Magoola M Niazi SK. Single chain variable fragment transferrin fusion protein (RNAT89) to treat neurodegenerative disorders. US Patent 2026\/0000776 A1. 2026 Jan 1."},{"key":"e_1_3_4_16_1","unstructured":"Alam R Croy JE Tani H. Multispecific binding molecules and methods of use thereof. WO 2023\/215697 A1. 2023 Nov 9."},{"key":"e_1_3_4_17_1","unstructured":"Sun W. Compounds for treating neurodegenerative diseases and cancers. WO 2020\/181026 A1. 2020 Sep 10."},{"key":"e_1_3_4_18_1","unstructured":"Edavettal S Singh S Domingo D et al. AntiCD98 antibodies and uses thereof. WO 2021\/205361 A1. 2021 Oct 14."},{"key":"e_1_3_4_19_1","unstructured":"Kou J Gong S Yu J et al. Application of cetrorelix. CN 117771344 A. 2024 Mar 29."},{"key":"e_1_3_4_20_1","unstructured":"Wang Z Fan Y He D. A GSK3\u03b1\/\u03b2 inhibitor capable of penetrating the bloodbrain barrier. CN 117064887 A. 2023 Nov 17."},{"key":"e_1_3_4_21_1","unstructured":"Patel HM. 1 3 4Thiadiazolebased propargylamine derivatives for selective inhibition of monoamine oxidaseB (MAOB) in the treatment of neurodegenerative disorders. IN 202521105840 A. 2025 Nov 28."},{"key":"e_1_3_4_22_1","unstructured":"Deng Y Chen J Shi Y et al. 2(Piperidinylalkyl)pyridazinone compounds and preparation method and use thereof. CN 121378212 A. 2026 Jan 23."},{"key":"e_1_3_4_23_1","unstructured":"Liang A Zhu J Wu Y et al. Compound for preventing and\/or treating neurodegenerative diseases. CN 118290396 A. 2024 Jul 5."},{"key":"e_1_3_4_24_1","unstructured":"Wang F Guo H Duan B et al. Monoterpenoid indole alkaloid and preparation method and application thereof AChE inhibitor and drug for preventing and treating neurodegenerative diseases. CN 119119068 A. 2024 Dec 13."},{"key":"e_1_3_4_25_1","unstructured":"Xie Y Lu Y Zhang C et al. Cinnamamide monohydroxypyridinone derivatives and preparation method and application thereof. CN 116768792 A. 2023 Nov 17."},{"key":"e_1_3_4_26_1","unstructured":"Al Shifa College of Pharmacy. Neuroprotective effect of taurine hybrids for the treatment of neurodegenerative disorders. IN 202241059343 A. 2022 Oct 28."},{"key":"e_1_3_4_27_1","unstructured":"Nitulescu II Gage FH Tucker JK. Chromen4one derivatives such as e.g. flavones for use as CK2 inhibitors for the treatment of neuroinflammation. WO 2021\/236578 A1. 2021 Nov 25."},{"key":"e_1_3_4_28_1","unstructured":"Wang Y Liu G Liu W. 2(3 6dimethyl5hydroxymethylpyrazin2)5methylpyrazole3one compound having antioxidation effect. WO 2022\/127050 A1. 2022 Jun 23."},{"key":"e_1_3_4_29_1","unstructured":"Zhang Y Xiao F Wang G et al. Use of crassifolin a in preparation of drug for promoting mitophagy and treating neurodegenerative diseases. WO 2023\/279957 A1. 2023 Jan 12."},{"key":"e_1_3_4_30_1","unstructured":"Yuhan Corporation. Macrocyclic pyrimidine derivatives and use thereof for preventing or treating neurodegenerative diseases. WO 2023\/113510. 2023 p. A1."},{"key":"e_1_3_4_31_1","unstructured":"Ibrahim MAMA Paris JR Walker LA et al. Orally bioavailable brainpenetrant compound with selectivity for the cannabinoid type 2 receptor with potential use towards visceral pain management and neurodegenerative disorders. US Patent 2023\/0303581 A1. 2023."},{"key":"e_1_3_4_32_1","unstructured":"Fluorinated synthetic cannabinoid analogues for treating ocular and neurodegenerative disorders. IN 202511075583 A. 2025 Aug 29."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.10.034"},{"key":"e_1_3_4_34_1","unstructured":"Dominguez C Bard J Lee MR et al. Compounds for targeting mutant huntingtin protein and uses thereof. WO 2020\/176424 A1. 2020."},{"key":"e_1_3_4_35_1","unstructured":"Xu J Feng J Zhou B et al. A hydrophobic tag compound for targeted degradation of Tau protein and its preparation and application. CN 119285633 A. 2025."},{"key":"e_1_3_4_36_1","unstructured":"Huang J Fan L Liu J et al. A wheat peptide with neuroprotective effects and its preparation method and application. CN 121378407 A. 2026."},{"key":"e_1_3_4_37_1","unstructured":"Cheng CT Hou KL Lau PY. Method for treating neurodegenerative diseases. WO 2024\/254192 A2. 2024."},{"key":"e_1_3_4_38_1","unstructured":"Rutkowski JL Walsh F Sinclair EH et al. BBBshuttlingVNARs conjugated to neurotrophic agonist antibodies to treat neurodegenerative diseases and conditions. WO 2021\/102276 A1. 2021."},{"key":"e_1_3_4_39_1","unstructured":"Li J Guo Z Zhang Q et al. Thioacetamide arylamine compounds as histone deacetylase subtype inhibitors and uses thereof. CN 111943892 A. 2020."},{"key":"e_1_3_4_40_1","unstructured":"Fu H Zhou J. A class of phenylamide compounds targeting CSF1R kinase and uses thereof. CN 118027009 A. 2024."},{"key":"e_1_3_4_41_1","unstructured":"Medicortex Finland Oy. Compositions and compositions for use in preventing or treating of brain damage and neurodegenerative diseases. Finnish Patent FM 130262 B. 2021."},{"key":"e_1_3_4_42_1","unstructured":"Xu P Wang M. Method for restoring microglia and astrocytes and use thereof. CN 119303108 A. 2025 Jan 14."},{"key":"e_1_3_4_43_1","unstructured":"Xu P Wang M. Braintargeted antibody nanoparticle for neurodegenerative diseases therapy. WO 2022\/235329 A1. 2022 Nov 10."},{"key":"e_1_3_4_44_1","unstructured":"Wu X He C Abbasi A et al. Bloodbrain barrierpenetrating nanotheranostics for acute and chronic neurodegenerative diseases and the like. WO 2022\/067430 A1. 2022 Apr 7."},{"key":"e_1_3_4_45_1","unstructured":"Gao H Lei T Jiang W et al. Oral braintargeted nanoemulsion and preparation method and application thereof. CN 120078718 A. 2025 Jun 3."},{"key":"e_1_3_4_46_1","unstructured":"Burgard G B\u00f6hnke R Benson S et al. Hyaluronidase polypeptide for use in the treatment or prophylaxis of a neurodegenerative disease. WO 2023\/067001 A1. 2023 Apr 27."},{"key":"e_1_3_4_47_1","unstructured":"Cho MH. Fusion comprising antitau antibody and peptide and use thereof. WO 2024\/123052 A1. 2024 Jun 13."},{"key":"e_1_3_4_48_1","unstructured":"Harel A. Conjugates and conjugates for use in preventing or treating of brain damage and neurodegenerative diseases. WO 2021\/038125 A2. 2021 Mar 4."},{"key":"e_1_3_4_49_1","unstructured":"Centre National de la Recherche Scientifique. Microbubble comprising a fluorinated polymer or copolymer and a fluorinated gas. WO 2025\/252843 A1. 2025."},{"key":"e_1_3_4_50_1","unstructured":"BNH Research Co. Ltd. Polymorphs of nitrogencontaining heterocyclic compounds and uses thereof. WO 2025\/071368 A1. 2025."},{"key":"e_1_3_4_51_1","unstructured":"Zhao X Zhang T Yue H et al. Application of zuotai in preparation of drugs for promoting MS275 to pass through bloodbrain barrier. CN 111202747 A. 2020."},{"key":"e_1_3_4_52_1","unstructured":"Genentech Inc. Modified antibody fcs and methods of use. WO 2020\/132230 A2. 2020."},{"key":"e_1_3_4_53_1","unstructured":"Farese RV Sajan MP. Use of auranofin as an inhibitor of atypical protein kinase C for treatment of neurodegenerative disorders. WO 2023\/076936 A1. 2023."},{"key":"e_1_3_4_54_1","unstructured":"Seenu A Priya N Singh K et al. pHresponsive cerium oxide nanozymes with zwitterionic ligands for targeted neuroprotective ROS scavenging. IN 202511085849. 2025."},{"key":"e_1_3_4_55_1","unstructured":"Chebrolu Hanumaiah Institute of Pharmaceutical Sciences. Nanostructured artificial organelles for targeted cellular modulation. IN 202541089898. 2025."},{"key":"e_1_3_4_56_1","unstructured":"Karpagam Academy of Higher Education Selvaraj H Gopalakrishnan GV. Double layered biodegradable oral dispensing film for Parkinson\u2019s disease. IN 202541129546 A. 2026."},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.inorgchem.6c00360"},{"key":"e_1_3_4_58_1","unstructured":"Universitat Zurich. Viral vectors for use in the treatment of brainbased diseases or disorders. WO 2021\/239308 A1. 2021."},{"key":"e_1_3_4_59_1","unstructured":"Universite Paris cite Institut National de la Sante et de la recherche Medicale. New inhibitors of LRRK2\/PP1 interaction. EP 4563586 A1. 2025."},{"key":"e_1_3_4_60_1","unstructured":"Zhejiang Gewuzhizhi biotechnology Co. Ltd. A combined detection kit for assisting diagnosis of Alzheimer\u2019s disease and application thereof. CN 116930510 A. 2023."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2725660","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2725660","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2725660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:25:35Z","timestamp":1793618735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2725660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/13543776.2026.2725660"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2725660","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}